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Introduction
Myocardial infarction (MI) remains one of the leading causes 
of death worldwide. New serological biomarkers, such as high 
sensitive troponins, have radically improved the diagnosis of 
MI, but even then, the diagnosis of MI can be still challenging. 
Cardiac magnetic resonance imaging (MRI) generates exquisite 
tissue contrast to characterize the myocardium, and late gado-
linium enhancement (LGE) is the current reference standard for 
non-invasive assessment of the presence of a myocardial scar 
(1). Additionally, cardiac MRI provides a robust means of struc-
tural and functional assessment of regional myocardial motion 
and thickening, rest and stress perfusion, and myocardial edema 
following an acute ischemic event. Post reperfused ST-elevation 
MI (STEMI), early and LGE also show other independent poor 
prognostic biomarkers such as microvascular obstruction (MVO) 
and intra-myocardial hemorrhage (IMH) (2, 3).
Standard cardiac MRI sequences and protocols for MI imaging
T2-weighted imaging for myocardial edema
Myocardial edema develops before ischemic necrosis or 
even troponin release (4), and it can persist for up to 1 month 
even when electrocardiogram changes and myocardial dysfunc-
tion resolves (5). Early studies have demonstrated that edema-
sensitive T2-weighted (T2W) imaging signiicantly improved the 
diagnostic power of cardiac MRI for MI by recognizing post-
ischemia edema (6). Moreover, in the same study, Cury et al. (6) 
demonstrated that T2W imaging accurately identiied all cases 
of acute MI, often before cardiac biomarkers were elevated. 
T2W cardiac MRI can also be used to determine the area at 
risk (AAR) in reperfused and non-reperfused infarction (Fig. 1). 
When combined with contrast-enhanced imaging, the salvaged 
area and thus the success of early coronary revascularization 
can be quantiied. Strong evidence for the prognostic value of 
myocardial salvage has facilitated its use as a primary endpoint 
in clinical trials.
LGE imaging for myocardial scar
The most validated cardiac MRI technique for myocardial 
scar assessment remains LGE imaging. LGE imaging employs an 
inversion recovery T1-weighted (T1W) gradient echo acquisition 
approximately 10 min after the intravenous administration of the 
gadolinium contrast. With appropriate settings, normal myocar-
dium appears black or nulled, whereas non-viable regions appear 
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bright or hyper-enhanced. Gadolinium contrast distribution vol-
ume and tissue concentration are low in normal myocardium. 
With acute necrosis (e.g., acute MI and myocarditis), there is 
membrane rupture, which allows gadolinium contrast to diffuse 
into the myocytes. This results in increased gadolinium con-
centration, shortened T1 relaxation, and hyper-enhancement. 
In the chronic MI setting, a scar replaces the necrotic tissue, 
and the interstitial myocardial space is expanded. This again 
leads to increased gadolinium concentration and hyper-en-
hancement.
Post MI, infarct size (IS) is a marker of the extent of dam-
age secondary to myocardial necrosis. It has been proposed as 
an imaging biomarker of clinical outcomes and as a measure of 
potential eficacy of new treatment approaches. IS and infarct 
shape on LGE imaging has been validated against histopathol-
ogy (7). Additionally, IS (quantiied as % of the left ventricular (LV) 
volume/mass) is an independent predictor of prognosis post MI 
(8). Depending on the extent of ischemia, the infarct can be lim-
ited to the sub-endocardium (with limited loss of viability) or be 
transmural in larger infarcts. Infarct transmurality assessment on 
LGE also predicts functional recovery post reperfusion therapy 
and has become an important clinical tool in routine cardiac MRI 
practice (9).
IS and transmurality on LGE imaging can be quantiied using 
manual contours (10-12) or by semi-automated image threshold-
ing techniques, which include enhancing myocardium exceed-
ing a pre-deined signal intensity (SI) threshold, typically 2-6 
standard deviations above that of remote (non-infarcted) myo-
cardium. Currently, the most validated and commonly used is the 
full-width at half maximum (FWHM) thresholding method (13), 
deining infarct as myocardium with an SI greater than 50% of 
the peak SI in the infarct core.
Limitations of T2W and LGE imaging
Conventional T2W images are acquired using the short-tau 
inversion recovery (STIR) sequence (14). Limitations of this tech-
nique include signal drop-out, bright signals adjacent to the sub-
endocardium due to slow-low blood, image quality impairment in 
tachyarrhythmias, and long breath-holds (15, 16). Moreover, there 
is need for a “normal” reference region of interest (ROI), either in 
remote myocardium, or in adjacent skeletal muscle for conditions 
with diffuse myocardial edema. The use of an ROI outside the myo-
cardium typically requires using the body-coil to minimize signal 
inhomogeneity, which gives a lower signal-noise-ratio. In systemic 
conditions like viral myocarditis, the reference skeletal muscle 
may also be inlamed, leading to false-negative results. In a pre-
clinical study, semi-automated, FWHM thresholding demonstrated 
promising results to quantify AARs (17). However, more recent evi-
dence has debated this in humans (18, 19), and currently, there is 
no consensus on the use semi-automated thresholding method on 
T2W imaging for the quantiication of myocardial edema.
Similarly, for LGE imaging, it is still debated if semi-automated 
segmentation techniques provide the best reproducibility be-
tween different users to quantify the IS (18, 20). Semi-automated 
thresholding method is dependent on several factors, including 
1) windowing by the operator to decide where the ROI is placed, 
2) the variation of SI within the ROI, and 3) the size of the ROI 
can also affect the signal intensity variations (21). The cumula-
tive effect of these factors can signiicantly inluence quantii-
cation and intra-/inter-observer variation of the measurements. 
Moreover, recent literature suggests that IS on LGE imaging has 
limited value in acute MI (22) and compared with histopathology, it 
overestimates the actual IS (23, 24). Also, SI changes seen with in-
farction do not necessarily represent extracellular matrix (25, 26).
Hence, there has been a drive to move toward more quanti-
tative methods for accurate and precise, in vivo assessment of 
histopathological changes in the myocardium.
Principles of T1 mapping
T1 mapping measures the longitudinal relaxation time of tis-
sue, which is determined by how rapidly proton spins re-equil-
ibrate their longitudinal magnetization after being excited by a 
radiofrequency pulse (27). T1 mapping refers to pixel-wise mea-
surement of absolute T1 relaxation times on a quantitative map. 
T1 mapping circumvents some of the issues of the inluence of 
windowing and nulling (as in LGE) and allows direct, pixel-wise 
T1 quantiication. T1 mapping has the potential to detect diffuse 
myocardial structural alterations not assessable by other non-
invasive methods and may be more sensitive than LGE in de-
tecting diffuse myocardial ibrosis (28). The two most important 
biological determinants of an increase in native T1 are edema 
(increase of tissue water in e.g., acute infarction of inlamma-
tion) and increase of collagen associated with rise in interstitial 
space [e.g., ibrosis of infarction (scar) or cardiomyopathy and 
in amyloid deposition]. Native T1 mapping is feasible even in pa-
tients with severe renal impairment in whom gadolinium-based 
contrast agents are contraindicated.
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Figure 1. Illustration demonstrating different cardiac magnetic reso-
nance imaging (MRI) techniques for infarct assessment. Note that only 
T1 map and extracellular volume (ECV) map inform about the extent of 
damage within the infarction
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Native T1 values are a composite signal of intracellular vol-
ume and ECV with the potential of pseudo-normalization of ab-
normal values (e.g., low native T1 values of the Anderson-Fabry 
disease cancelled out by the presence of infarction/ibrosis). 
Native T1 values are inluenced by the scanner’s static mag-
netic ield strength, with higher native T1 values at 3T than at 
1.5T. The accuracy and precision of measured T1 values depends 
on the pulse sequence used. The most commonly used methods 
in clinical practice are Modiied Look Locker Inversion recov-
ery (MOLLI) and short MOLLI (shMOLLI) as well as Saturation 
Recovery Single Shot Acquisition (SASHA). Of these methods, 
SASHA appears to be more accurate but less reproducible than 
MOLLI and shMOLLI, which tend to underestimate the absolute 
T1 value (29). Another disadvantage of MOLLI sequences is that 
they interleave images from three inversion recoveries, which 
results in a long breath-hold and some heart rate dependency 
(29). ShMOLLI sequences have been developed to reduce heart 
rate dependency and breath-hold and may be more clinically ap-
plicable for patients who experience breathlessness (30).
T1 is also sensitive to the choice of readout lip angle used in 
inversion recovery sequences and the cardiac phase (diastole 
versus systole). Normal native T1 values are thus speciic to the 
imaging set up, and changes to the acquisition method may result 
in changes to T1 values. Additionally, there can be regional varia-
tion of T1 values across normal myocardium and hence placement 
of ROI used to assess T1 requires consistency (31). Placement of 
ROI also needs to avoid partial volume effects at the blood–myo-
cardium boundary, where myocardium values may be artiicially 
increased by the inclusion of blood pool in the pixels of interest. 
However, high intra-observer, inter-observer, and inter-study re-
producibility can be achieved with consistent methodology (31).
Contrast-enhanced T1 mapping is mostly used for calculating 
the ECV fraction in combination with native T1 mapping. Standard 
gadolinium-based contrast agents are distributed throughout the 
extracellular space and shorten T1 relaxation times of the myo-
cardium proportional to the local concentration of gadolinium. 
Areas of ibrosis and scar will therefore exhibit shorter T1 relax-
ation times than healthy tissue after contrast administration. The 
hematocrit represents the cellular fraction of blood. Estimation of 
ECV (interstitial and extracellular matrix) requires the measure-
ment of myocardial and blood T1 before and after the administra-
tion of contrast agents as well as the patient’s hematocrit value 
(27). The ECV formula is as follows:
ECV = (1 Ȅ hematocrit) ࡧ (1/post-contrast T1 myo Ȅ 1/native T1 
myo)/(1/post-contrast T1 blood Ȅ 1/native T1 blood)
ECV is a marker of myocardial tissue remodeling and pro-
vides a physiologically intuitive unit of measurement with normal 
ECV values of 25.3±3.5% in normal myocardium (27).
In future, the requirement for an additional blood test to de-
rive hematocrit could be avoided using the so-called synthetic 
ECV formulas (32, 33). Synthetic ECV is calculated by estimating 
the hematocrit from native T1 values of blood pool within the LV. 
Currently, this has been validated on 1.5T Siemens systems (32) 
and 1.5T/3T Philips systems (33). The equations for computing 
synthetic ECV are listed in Table 1.
ECV can either be calculated for myocardial ROIs or visualized 
on ECV maps. As ECV is derived from the ratio of T1 signal values 
and is expressed in percentage (%), it is less inluenced by the dif-
Cine T2-weighted T1-Maps
EGE LGE ECV-maps
Figure 2. In vivo histopathology assessment by multi-parametric car-
diac magnetic resonance imaging (MRI) of a patient who presented 
with acute ST-elevation myocardial infarction. On cine images, inferio-
lateral segments demonstrate increased thickness secondary to myo-
cardial edema. T2-weighted imaging (white arrow) and T1 maps (white 
arrow) conirm the presence of myocardial edema. A hypointense core 
is seen on T2-weighted imaging, which is consistent with the diagnosis 
of intra-myocardial hemorrhage (orange arrow). This is also present in 
EGE imaging and LGE imaging conirming the presence of MVO. LGE im-
aging conirms large infero-lateral MI and MVO. ECV maps demonstrate 
>60% ECV in the scar tissue, suggesting severe tissue damage (black 
arrows). Also, note that IMH/MVO within the infarct results in pseudo-
normalization of native T1 and ECV
Table 1. Synthetic hematocrit formulas for different magnetic resonance systems to derive synthetic extracellular volume
Vendor Field strength Synthetic hematocrit formula  Ref.
Siemens 1.5 Tesla Synthetic Hct MOLLI=(866.0·[1/T1blood])Ȅ0.1232 (32)
Siemens 1.5 Tesla Synthetic Hct ShMOLLI=(727.1·[1/T1blood])Ȅ0.0675 (32)
Philips 1.5 Tesla Synthetic Hct MOLLI=(922.6·[1/T1blood])–0.1668 (33)
Philips 3 Tesla Synthetic Hct MOLLI=(869.7·[1/T1blood])–0.071 (33)
Hct - hematocrit; MOLLI - Modiied Look Locker Inversion recovery; shMOLLI - short Modiied Look Locker Inversion recovery; Ref - references
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ferent ield strengths, vendors, and acquisition techniques versus 
native or post-contrast T1 (34). This makes ECV more robust for im-
aging biomarker for clinical applications across all vendors. ECV 
measures also exhibit better agreement with histological measures 
of the collagen volume fraction than with isolated post-contrast 
T1 (35). However, it should be noted that low ECV values occur in 
thrombus, MVO, IMH, and fat/lipomatous metaplasia (Fig. 2).
In patients with acute or chronic MI, T1 mapping and ECV pro-
vide complementary information to standard LGE imaging, both 
diagnostically and prognostically (Table 2).
Acute MI
Differentiation between acute and chronic MI can be of clini-
cal relevance because both disorders require a different diag-
nostic work-up, including conventional coronary angiography 
and medical therapy. Myocardial edema develops within minutes 
of coronary occlusion secondary to ischemia and resolves over 
weeks or sometimes months after MI. Native T1 reliably detects 
segmental abnormalities caused by acute MI with high sensitivity 
and speciicity (36). Also, T1 mapping detects myocardial edema 
in both STEMI and non-STEMI patients and is at least as sensi-
tive as T2-STIR, in particular in patients with smaller IS (36). A re-
cent study demonstrated that native T1 maps perform better than 
T2W imaging in differentiating acute from chronic MI (area under 
the curve 0.97 versus 0.86, p<0.01) (37). Furthermore, T1 values 
progress from normal myocardium to that of maximal injury and 
can be used for deining the peri-infarct zone/AAR in combination 
with LGE imaging (5). Native T1 values in acute MI are high, and 
ECV values are among the highest of all cardiac disease (56±1.4) 
(38), most likely due to the disruption of cardiomyocyte membrane 
integrity and subsequent expansion of the distribution volume of 
extracellular contrast agents.
Infarct core: Intensity of damage within the infarct is 
prognostically relevant
Native T1 in the infarct core predicts 6-month mortality in 
STEMI patients even after adjustment for LV ejection fraction (39). 
Similarly, a study investigating the ability of acute infarct ECV and 
acute transmural extent of LGE to predict convalescent function 
demonstrated that ECV had higher accuracy than LGE extent in 
predicting improved wall motion (area under the curve was 0.77 
versus 0.66; p=0.02). In the same study, an infarct ECV of <50% had 
81% sensitivity and 65% speciicity for the prediction of improve-
ment in segmental function at follow-up and on the contrary, LGE 
transmural extent ≤0.5 had 61% sensitivity and 71% speciicity.
Remote myocardium: adverse tissue level remodeling in 
normal myocardium
T1 mapping and ECV have also been used to predict remote 
myocardial remodeling after STEMI. In a study by Carrick et al. 
Table 2. Comprehensive assessment by multi-parametric cardiac magnetic resonance imaging in patients presenting with 
myocardial infarction
Regional and global LV functional assessment
Volumetric cine imaging
Myocardial edema assessment
T2-weighted imaging
T1 or T2 maps
ECV (>33%)
Microvascular obstruction and LV thrombus assessment
Early gadolinium enhancement imaging
Intra-myocardial hemorrhage assessment 
T2-weighted imaging (hypointense core in the infarcted area)
T2 maps or T2-star maps
Infarct size/viability assessment to predict functional recovery and prognosis
LGE imaging
Native T1 maps
ECV maps (Acute MI infarct size: ECV >46%)
Extent of damage within the infarct to predict functional recovery and prognosis 
Native T1 maps and/or ECV maps (>50% ECV is associated with poor functional recovery in respective segments)
Myocardial salvage index 
[AAR (% of LV on T2-weighted imaging) Ȅ IS (% of LV, on LGE)]/AAR (% of LV on T2-weighted imaging)
or
[AAR (% of LV with ECV >33%) Ȅ IS (% of LV with ECV >46%)]/AAR (% of LV with ECV >33%)
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(40), native remote myocardium T1 predicted LV adverse remod-
eling in patients with acute MI. In a more recent work by the same 
group, acute remote zone ECV and changes in ECV (between 
acute and follow-up visit) were associated with MI severity (41). 
However, the authors concluded that changes in acute/follow-up 
ECV in remote zone were small and had limited use as a clinical 
biomarker of remodeling. More recently, we demonstrated that 
segmental ECV expansion of normal myocardium is associated 
with worsening contractile function (42).
Quantiication of AAR and IS
Another recent study in a STEMI population demonstrated 
that acute ECV maps could be used to quantify AAR and IS on both 
1.5T and 3T systems (43). The ECV threshold for AAR was 33% and 
46% for IS. ECV maps demonstrated better agreement with inal IS 
than with acute IS on LGE [ECV maps: bias, 1.9; 95% conidence 
interval (CI), 0.4-3.4 versus LGE imaging: bias, 10; 95% CI, 7.7–12.4]. 
More recently, native T1 maps have also been used to distinguish 
between reversible (injured myocardial cells with edema) and ir-
reversible (necrosed myocardial cells leading to permanent scar) 
injury post STEMI (44). T1 cut-off values for edematous versus 
necrotic myocardium were identiied as 1251 ms and 1400 ms on 
a 3T MR system. Additionally, a native T1 threshold of 1400 ms 
for IS volume demonstrated a good agreement with 6-month LGE 
IS (r=0.99). T1-derived infarct extent strongly correlated with the 
log area under the curve troponin (r=0.80) and 6-month ejection 
fraction (r=Ȅ0.73). Quantiication thresholds for IS and AAR are 
lacking for native T1 mapping on 1.5T MR systems.
Being able to accurately quantify AAR and MI size using a 
pixel-wise quantitative map would be appealing and could be 
potentially easily implemented in clinical practice with the wider 
availability of in-line, automated map generation from the scan-
ner, to improve worklow. However, more validation work is need-
ed across vendor platforms and ield strengths before reliable 
quantiication of AAR, IS and myocardial salvage index can be 
made from quantitative native T1 or ECV maps.
Challenges of T1 mapping in acute MI
Undertaking comprehensive cardiac MRI in acute infarct pa-
tients can be challenging because of multiple breath-holds re-
quired, patients having to lie lat in the scanner, and relatively 
long acquisition times. The majority of studies included in this 
review were conducted in small selected patient groups and in 
expert centers, and it remains unclear if they can be translated 
to clinical routine. However, free breathing cardiac T1 mapping 
sequences, which may improve clinical feasibility, are being de-
veloped (45). MVO in the infarct core (no-relow phenomenon) 
results in a pseudo-normalization of T1 values in this area and 
if not factored in, can result in the underestimation of the extent 
of injury (36). Additionally, T1 can even be decreased in the case 
of IMH, which is due to the accumulation of methemoglobin (T1 
shortening effect). Most of the above discussed studies were 
conducted within 4–5 days of the index presentation. However, 
it is well recognized that acute MI size is dynamic and acutely 
reduces in size within the irst week. Hence, clinical cardiac MRI 
protocols aimed to characterize acute MI need to be standard-
ized to take into account the dynamic biological changes post-
acute myocardial ischaemic injury. More recently, a pre-clinical 
and in vivo study demonstrated that post-MI myocardial edema 
follows a bimodal pattern, which affects cardiac MRI estimates 
of AAR (46). According to the study indings, a time window be-
tween day 4 and 7 post-MI seems a good compromise solution for 
standardization. It is also note-worthy that multi-parametric as-
sessment can offer mechanistic insights into infarct-associated 
complications and differential diagnosis (47, 48).
Chronic MI
In chronic MI, the necrotic and edematous infarct tissue of an 
acute infarct is replaced by a smaller area of increased extracel-
lular collagen (ibrous scar). Native T1 values are therefore lower 
Cine imaging
EGE-imaging
LGE-imaging
Figure 3. Post-acute myocardial infarct complication: inferior wall rup-
ture and pseudoaneurysm formation (orange arrows demonstrate the 
uptake of hyper-enhancement during LGE imaging) with a large immo-
bile mural thrombus within the pseudoaneurysm cavity (yellow arrows)
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Figure 4. Cardiac MRI MI protocol
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and less extensive in chronic MI than in acute MI (49). The ECV 
of chronically infarcted myocardium has been shown to be mark-
edly elevated (51±8%) compared with that of normal myocardium 
but slightly lower than in acutely infarcted myocardium. T1 map-
ping is also able to illustrate areas of lipomatous metaplasia in 
chronic MI, the presence of which alters the electrical properties 
of the myocardium and might play a role in post-MI arrhythmo-
genesis. Fat has very low T1 values (230-350 ms at 1.5 T), and the 
fatty replacement area within the infarct core therefore displays 
noticeable T1 decrease. It is worth noting that in chronic MI, the 
remote myocardial native T1 is independently associated with LV 
systolic dysfunction (50) again afirming the fact that post-MI LV 
remodeling is more global and also results in diffuse ibrosis in 
the remote myocardium.
Cardiac MRI MI protocol
As previously discussed in this review, cardiac MRI protocol 
for MI should be able to perform differential diagnosis, differ-
entiate between acute and chronic MI, aid in the quantiication 
of AAR, IS, and subsequent viability, inform about the intensity of 
damage within the infarct zone, and inally appropriately deine 
and explain any post-infarct complications (Fig. 3). We proposed 
a multi-parametric cardiac MRI MI protocol, which is detailed in 
Figure 4. This cardiac MRI MI protocol will facilitate a comprehen-
sive evaluation and has been tested in several studies (2, 3, 42, 43).
Conclusion
Although more pre-clinical validation and human clinical 
studies need to be conducted, it is evident that native T1 and 
ECV mapping can add to the assessment of acute and chronic 
MI patients and may have advantages over conventional cardiac 
MRI methods. The prospect of a rapid native T1 mapping protocol 
for patients who cannot tolerate a longer cardiac MRI scan or 
in those with contraindications to contrast usage is promising. 
Pixel-wise, T1 and ECV maps not only allow IS and AAR assess-
ment but also inform about the extent of damage within the scar, 
which is associated with both functional recovery and progno-
sis. In both acute and chronic MI, native T1 maps and ECV maps 
are paving the road for a more automated, user-independent, 
advanced analysis, which will eventually inform future clinical 
studies and trials testing the potential eficacy of new therapeu-
tic approaches.
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